Literature DB >> 1655370

Carcinoma and the ileal pouch-anal anastomosis.

O Wiltz1, H F Hashmi, D J Schoetz, P L Roberts, J J Murray, J A Coller, M C Veidenheimer.   

Abstract

Of 362 patients undergoing ileal pouch-anal anastomosis, 12 (five with chronic ulcerative colitis and seven with familial adenomatous polyposis) had 16 associated carcinomas. Incidental carcinoma was found in four patients who had undergone ileal pouch-anal anastomosis, six patients had known carcinoma, and carcinoma was suspected in two patients with high-grade dysplasia. No tumor was Stage C or D. After a median observation period of 24 months, no evidence of recurrence was documented. Data suggest that patients with carcinoma complicating chronic ulcerative colitis and familial adenomatous polyposis can safely undergo ileal pouch-anal anastomosis; however, it may be prudent to perform resection and later ileal pouch-anal anastomosis after a period of observation and appropriate adjuvant therapy because of the difficulty in intraoperative staging.

Entities:  

Mesh:

Year:  1991        PMID: 1655370     DOI: 10.1007/bf02051075

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  3 in total

1.  Proctocolectomy for colorectal cancer--is the ileal pouch anal anastomosis a safe alternative to permanent ileostomy?

Authors:  Ryan Snelgrove; Carl J Brown; Brenda I O'Connor; Harden Huang; J Charles Victor; Robert Gryfe; Helen MacRae; Zane Cohen; Robin S McLeod
Journal:  Int J Colorectal Dis       Date:  2014-10-17       Impact factor: 2.571

2.  Decision analysis in the surgical treatment of patients with familial adenomatous polyposis: a Dutch-Scandinavian collaborative study including 659 patients.

Authors:  H F Vasen; P van Duijvendijk; E Buskens; C Bülow; J Björk; H J Järvinen; S Bülow
Journal:  Gut       Date:  2001-08       Impact factor: 23.059

3.  Ulcerative colitis and coexisting colorectal cancer: recurrence rate after restorative proctocolectomy.

Authors:  Y Ziv; V W Fazio; S A Strong; J R Oakley; J W Milsom; I C Lavery
Journal:  Ann Surg Oncol       Date:  1994-11       Impact factor: 5.344

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.